Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: kyron.bio x Servier strategic partnership

Lucid Diligence Brief: kyron.bio x Servier strategic partnership Professional…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 9, 2026

This week’s Artificial Intelligence and Digital Health update highlights…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Medtronic / GE HealthCare patient monitoring alliance expansion

Lucid Diligence Brief: Medtronic / GE HealthCare patient monitoring alliance…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Cognito Therapeutics $105 million Series C

Lucid Diligence Brief: Cognito Therapeutics $105 million Series C Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration

Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: GAIA and Daiichi Sankyo Europe partnership on lipodia

Lucid Diligence Brief: GAIA and Daiichi Sankyo Europe partnership on lipodia…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Poplar Therapeutics $95 million Series A

Lucid Diligence Brief: Poplar Therapeutics $95 million Series A extension…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and Tedopi

Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 2, 2026

 This week’s AI in Healthcare and Digital Health update highlights…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”

Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC

Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC Professional…


Privacy Preference Center